O
ORIC
Oric Pharmaceuticals, Inc.
11.11
-0.22-1.94%After Hours: 10.94 -0.17 -1.53%18:53 02/20 EST
OPEN/PREV CLOSE11.17/11.33
TODAY RANGE10.80-11.35
VOL1.11M
MARKET CAP1.08B
52 WEEK RANGE3.895-14.93
AVG VOL (3M)1.49M
% TURNOVER1.14%
TURNOVER--
P/E (TTM)-6.4183
% RANGE4.85%
EPS(TTM)-1.7310
P/E(FORWARD)-7.1909
P/B2.656
BVPS4.183
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP967.69M
SHARES OUTSTANDING97.39M
NEXT EARNINGS02/20-03/02
FREE FLOAT87.10M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·02/05 21:01
ORIC Pharmaceuticals to Participate in Major Investor Conferences
Reuters·02/05 21:01
Oric Pharmaceuticals nimmt an mehreren führenden Investorenkonferenzen teil
Simply Wall St·01/26 01:16
How Investors Are Reacting To ORIC Pharmaceuticals (ORIC) Big-Pharma Partnerships And Cancer Resistance Pipeline
TipRanks·01/23 13:07
JonesTrading Issues a Buy Rating on Oric Pharmaceuticals (ORIC)
Seeking Alpha·01/20 18:36
ORIC Pharmaceuticals: Transition To Late-Stage Development Presents Upside
TipRanks·01/20 10:59
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
Simply Wall St·01/18 12:18
ORIC Pharmaceuticals (ORIC) Is Up 32.5% After J&J Lung Cancer Collaboration and Pipeline Update - What's Changed
Simply Wall St·01/16 03:47
Assessing ORIC Pharmaceuticals (ORIC) Valuation After Fresh Buy Ratings And Johnson & Johnson Collaboration
TipRanks·01/13 14:38
Wedbush Sticks to Their Buy Rating for Oric Pharmaceuticals (ORIC)
Same Industry
Name/Symbol
Change%
Price